Clinical Trial Results:
A multiple-dose, double-blind, placebo-controlled, parallel study to assess the efficacy, safety and tolerability of ACZ885 (Canikumab) in patients with pulmonary sarcoidosis
Summary
|
|
EudraCT number |
2013-005333-21 |
Trial protocol |
NL |
Global completion date |
01 Jul 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
01 May 2019
|
First version publication date |
30 Mar 2019
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
Termination Letter_CACZ885X2202 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.